Institute for Chemistry and Technology of Biobased Systems (IBioSys), Graz University of Technology, Stremayrgasse 9, 8010 Graz, Austria.
Faculty of Mechanical Engineering, Institute of Engineering Materials and Design, University of Maribor, Smetanova 17, 2000 Maribor, Slovenia.
ACS Appl Mater Interfaces. 2022 Jan 26;14(3):3726-3739. doi: 10.1021/acsami.1c19577. Epub 2022 Jan 11.
The path to greater sustainability and the development of polymeric drug delivery systems requires innovative approaches. The adaptation and use of biobased materials for applications such as targeted therapeutic delivery is, therefore, in high demand. A crucial part of this relates to the development of porous and hollow structures that are biocompatible, pH-responsive, deliver active substances, and contribute to pain relief, wound healing, tissue regeneration, and so forth. In this study, we developed a facile single-step and water-based method for the fabrication of hollow spherical cellulose beads for targeted drug release in response to external pH stimuli. Through base-catalyzed deprotection, hydrophobic solid and spherical cellulose acetate beads are transformed into hydrophilic cellulose structures with a hollow interior (wall thickness: 150 μm and inner diameter: 650 μm) by a stepwise increment of temperature and treatment time. Besides the pH-responsive fluid uptake properties, the hollow cellulose structures exhibit a maximum encapsulation efficiency of 20-85% diclofenac (DCF), a nonsteroidal anti-inflammatory drug, used commonly to treat pain and inflammatory diseases. The maximum amount of DCF released increased from 20 to 100% when the pH of the release medium increased from pH 1.2 to 7.4. As for the DCF release patterns and kinetic models at specific pH values, the release showed a diffusion- and swelling-controlled profile, effortlessly fine-tuned by external environmental pH stimuli. Overall, we show that the modified beads exhibit excellent characteristics for transport across the gastrointestinal tract and enhance the bioavailability of the drug. Their therapeutic efficacy and biocompatibility are also evident from the studies on human fibroblast cells. We anticipate that this platform could support and inspire the development of novel sustainable and effective polysaccharide-based delivery systems.
实现更大的可持续性和开发聚合物药物输送系统需要创新方法。因此,对于靶向治疗输送等应用,生物基材料的适应性和使用需求很高。这方面的一个关键部分涉及开发多孔和中空结构,这些结构具有生物相容性、pH 响应性、能够输送活性物质,并有助于缓解疼痛、促进伤口愈合、组织再生等。在这项研究中,我们开发了一种简便的单步水基方法,用于制造中空球形纤维素珠,以响应外部 pH 刺激进行靶向药物释放。通过碱催化脱保护,疏水性固体和球形醋酸纤维素珠通过逐步升温处理时间,转化为具有中空内部(壁厚:150μm,内径:650μm)的亲水性纤维素结构。除了 pH 响应的流体吸收特性外,中空纤维素结构还表现出 20-85%的双氯芬酸(DCF)的最大包封效率,DCF 是一种常用的治疗疼痛和炎症性疾病的非甾体抗炎药。当释放介质的 pH 从 1.2 增加到 7.4 时,DCF 的最大释放量从 20%增加到 100%。对于特定 pH 值下的 DCF 释放模式和动力学模型,释放显示出扩散和溶胀控制的特征,很容易通过外部环境 pH 刺激进行微调。总体而言,我们表明修饰后的珠子具有穿过胃肠道的优异特性,并提高了药物的生物利用度。从对人成纤维细胞的研究中也可以明显看出它们的治疗效果和生物相容性。我们预计,该平台将支持和启发新型可持续和有效的多糖基输送系统的开发。